GGrantIndex
Sort

51,593 grants matching hepatitis

A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans

$655,032
Kelly E Dunn · Johns Hopkins University · R01 · FY2017 · DA

Lead optimization of Hepatitis B Virus ribonuclease H inhibitors

$654,955
John E Tavis · Saint Louis University · R01 · FY2021 · AI

Data Coordinating and Image Analysis for CRISP-II

$654,939
Kyongtae T Bae · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · DK

Addressing Hepatitis C and Hepatocellular Carcinoma: Current and Future Epidemics

$654,934
Holly C. Hagan · New York University · R01 · FY2016 · DA

Functional Interactions Between Lipoproteins and Protease Inhibitors in Atherosclerosis

$654,890
Scott M Gordon · University Of Kentucky · R01 · FY2025 · HL

Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers

$654,870
Luke Norton · University Of Texas Hlth Science Center · R01 · FY2024 · DK

HIV AND HCV DISEASE PROGRESSION IN WOMEN ON HAART

$654,771
Andrea A. Kovacs · University Of Southern California · R56 · FY2014 · AI

Cell Type Specific Roles of ApoE2 in Tissue Inflammation and Atherosclerosis

$654,752
David Y Hui · University Of Cincinnati · R01 · FY2017 · HL

Cell Type Specific Roles of ApoE2 in Tissue Inflammation and Atherosclerosis

$654,752
David Y Hui · University Of Cincinnati · R01 · FY2018 · HL

Cell Type Specific Roles of ApoE2 in Tissue Inflammation and Atherosclerosis

$654,752
David Y Hui · University Of Cincinnati · R01 · FY2019 · HL

Biochemistry and Genetics of Hepatocarcinogenesis

$654,695
Christopher A Bradfield · University Of Wisconsin-Madison · P01 · FY2006 · CA

Small Molecule Inhibitors Targeting Adenovirus

$654,679
Charles E McKenna · University Of Southern California · R01 · FY2019 · AI

A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)

$654,671
Xuanyong Lu · Imcare Biotech, Inc. · R44 · FY2017 · CA

Dietary Regulation of Intestinal Inflammation and Repair

$654,662
David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DK

Community-based interventions to reduce mortality from neonatal infection

$654,658
Waldemar A. Carlo · University Of Alabama At Birmingham · U01 · FY2010 · HD

Exploring barriers and facilitators to women who use drugs (WWUD) awareness, acceptance and uptake of COVID-19 testing, the CARE study.

$654,592
Susan Gail Sherman · Johns Hopkins University · R01 · FY2021 · DA

STD and AIDS Research Training Grant

$654,518
Sheila A. Lukehart · University Of Washington · T32 · FY2019 · AI

Exposome and Precision Medicine in NAFLD

$654,500
Matthew C Cave · University Of Louisville · R01 · FY2020 · ES

Carbohydrate-Mediated Platelet Clearance

$654,455
Karin Maria Hoffmeister · Versiti Wisconsin, Inc. · R01 · FY2019 · HL

Pathways Towards Immune Tolerance To Coagulation Factors

$654,455
Roland W. Herzog · Wistar Institute · P01 · FY2010 · HL

Psychoeducation for HCV and Alcohol Behaviors

$654,419
Carol S North · Ut Southwestern Medical Center · R01 · FY2009 · AA

Discrimination of nonself by innate immune receptors

$654,379
Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Murine Typhus: Vector Biology and Transmission

$654,237
Abdu F Azad · University Of Maryland Baltimore · R01 · FY2013 · AI

Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis

$654,181
Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2012 · CA

Studies on RNAi Based Delivery in Vivo

$654,135
Mark A Kay · Stanford University · R01 · FY2010 · DK